Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Brazil
Brazil: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 86.0% in 2024. ▲ Rising
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Brazil, 2010–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
Brazil recorded 86.0% for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in 2024.
The figure is up 16.2% on the previous year and down 7.5% over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Brazil peaked at 94.0% in 2013 and was at its lowest, 24.0%, in 2010.
That places Brazil 83rd out of 146 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 15 years of available data.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Brazil, year by year
| Year | % | Change |
|---|---|---|
| 2010 | 24.0% | — |
| 2011 | 82.0% | +241.7% |
| 2012 | 88.0% | +7.3% |
| 2013 | 94.0% | +6.8% |
| 2014 | 93.0% | -1.1% |
| 2015 | 94.0% | +1.1% |
| 2016 | 84.0% | -10.6% |
| 2017 | 82.0% | -2.4% |
| 2018 | 80.0% | -2.4% |
| 2019 | 78.0% | -2.5% |
| 2020 | 79.0% | +1.3% |
| 2021 | 69.0% | -12.7% |
| 2022 | 72.0% | +4.3% |
| 2023 | 74.0% | +2.8% |
| 2024 | 86.0% | +16.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 79.9% | 24.0% | 94.0% | 10 |
| 2020s | 76.0% | 69.0% | 86.0% | 5 |
Countries ranked near Brazil
- 83 Kyrgyzstan 86.0% compare
- 83 Lesotho 86.0% compare
- 83 Niger 86.0% compare
- 83 Sao Tome and Principe 86.0% compare
More health data for Brazil
- Un projection of annual infant deaths, annual growth rate -1.86 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.1539 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,496 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,476 deaths (2100)
- Population ages 0-14, female, annual growth rate -1.05 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.095 units per person (2025)
- Population ages 0-14, male, annual growth rate -1.03 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.0989 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Brazil?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Brazil was 86.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Brazil?
- The highest recorded value was 94.0% in 2013.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Brazil?
- The lowest recorded value was 24.0% in 2010.
- How does Brazil rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Brazil ranks 83rd out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Brazil?
- Over the last ten years it is down 7.5%. The long-run trend across the full record is rising.
- Where does this Brazil data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.